Edward D. Esplin: Universal Germline Genetic Testing Standard of Care for Prostate Cancer
Edward D. Esplin, Clinical Geneticist at Invitae, shared a recent article on LinkedIn:
“Universal Germline Genetic Testing Standard of Care for Patients with Prostate Cancer: The Time Is Now.
We recommend that all patients with prostate cancer should be offered comprehensive germline genetic testing”
Authors: Neal Shore, Sarah M. Nielsen, Edward D. Esplin, Emmanuel S. Antonarakis, Pedro C. Barata, Tomasz M. Beer, Himisha Beltran, Alan Bryce, Michael S. Cookson, E. David Crawford, Tanya B. Dorff, Daniel J. George, Elisabeth I. Heath, Brian T. Helfand, Maha Hussain, Rana R. Mckay, Alicia K. Morgans, Michael J. Morris, Channing J. Paller, Ashley E. Ross, Oliver Sartor, John Shen, Paul Sieber, Matthew R. Smith, David R. Wise and Andrew J. Armstrong
Correlation with PROCLAIM trial:
More posts featuring Edward D. Esplin.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023